Production (Stage)
Haemonetics Corporation
HAE
$66.06
-$0.10-0.15%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 308.07M | 322.58M | 300.03M | 346.07M | 180.47M |
| Total Receivables | 202.66M | 211.95M | 213.53M | 201.49M | 206.56M |
| Inventory | 365.14M | 359.61M | 382.11M | 373.79M | 317.20M |
| Prepaid Expenses | 58.83M | 110.47M | 60.20M | 55.32M | 63.16M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 278.00K | 1.26M | 32.00K | 1.92M | 1.51M |
| Total Current Assets | 934.98M | 1.01B | 955.90M | 978.58M | 768.90M |
|
|
|||||
| Total Current Assets | 934.98M | 1.01B | 955.90M | 978.58M | 768.90M |
| Net Property, Plant & Equipment | 331.54M | 286.11M | 300.48M | 302.48M | 366.63M |
| Long-term Investments | 604.27M | 605.27M | 616.16M | 613.35M | 565.08M |
| Goodwill | 604.27M | 605.27M | 616.16M | 613.35M | 565.08M |
| Total Other Intangibles | 499.74M | 465.62M | 487.84M | 494.94M | 429.02M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 79.40M | 164.34M | 164.85M | 144.04M | 65.90M |
| Total Assets | 2.45B | 2.53B | 2.53B | 2.54B | 2.20B |
|
|
|||||
| Total Accounts Payable | 67.00M | 62.99M | 69.24M | 76.93M | 73.36M |
| Total Accrued Expenses | 59.42M | 45.93M | 49.30M | 40.77M | 80.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 311.67M | 5.08M | 5.43M | 5.11M | 18.36M |
| Total Finance Division Other Current Liabilities | 140.03M | 139.24M | 149.97M | 137.27M | 127.96M |
| Total Other Current Liabilities | 140.03M | 139.24M | 149.97M | 137.27M | 127.96M |
| Total Current Liabilities | 578.11M | 253.23M | 273.95M | 260.08M | 300.38M |
|
|
|||||
| Total Current Liabilities | 578.11M | 253.23M | 273.95M | 260.08M | 300.38M |
| Long-Term Debt | 921.23M | 1.22B | 1.22B | 1.22B | 797.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 50.45M | 68.56M | 88.23M | 73.16M | 57.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 80.32M | 82.85M | 62.89M | 83.89M | 79.73M |
| Total Liabilities | 1.63B | 1.62B | 1.65B | 1.64B | 1.24B |
|
|
|||||
| Common Stock & APIC | 523.75M | 570.13M | 544.88M | 561.39M | 635.14M |
| Retained Earnings | 352.17M | 392.23M | 368.54M | 386.64M | 360.46M |
| Treasury Stock & Other | -55.08M | -55.50M | -34.56M | -42.67M | -35.63M |
| Total Common Equity | 820.84M | 906.86M | 878.85M | 905.37M | 959.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 820.84M | 906.86M | 878.85M | 905.37M | 959.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 820.84M | 906.86M | 878.85M | 905.37M | 959.96M |
|
|
|||||